Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Paramythiotis, D., Michalopoulos A., Papadopoulos V. N., Panagiotou D., Papaefthymiou L., Digkas E., et al. (2011).  Gossypiboma presenting as mesosigmoid abscess [corrected].. Tech Coloproctol. 15 Suppl 1, S67-9.
Lazaridou, M. Nikolaou, Katopodi T., & Dimitrakopoulos I. (2015).  Gorlin-Goltz syndrome: a 25-year follow-up of a familial case.. Oral Maxillofac Surg. 19(1), 79-84.
Giannakoulas, G., & Boutsikou M. (2015).  The Gordian knot of thromboembolism in congenital heart disease.. Heart. 101(19), 1523-4.
Karagiannis, A., & Harsoulis F. (2005).  Gonadal dysfunction in systemic diseases.. Eur J Endocrinol. 152(4), 501-13.
Sotiriadis, A., Diamanti E., & Chatzinikolaou F. (2015).  Goldenhar syndrome presenting atypically with an additional cranial bone.. Ultrasound Obstet Gynecol. 45(3), 352-3.
Christopoulou-Aletra, H., Papavramidou N., & Pozzilli P. (2007).  Goitrous beauty in Artemisia Gentileschi's Judith and her Maidservant.. Thyroid. 17(1), 37-8.
Papanikolaou, E. G., Pados G., Grimbizis G., Bili E., Kyriazi L., Polyzos N. P., et al. (2012).  GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.. Hum Reprod. 27(6), 1822-8.
Humaidan, P., Polyzos N. P., Alsbjerg B., Erb K., Mikkelsen A. L., Elbaek H. O., et al. (2013).  GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.. Hum Reprod. 28(9), 2511-21.
Kolibianakis, E. M., Griesinger G., & Venetis C. A. (2018).  GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions.. Hum Reprod Update.
Prapas, Y., Petousis S., Dagklis T., Panagiotidis Y., Papatheodorou A., Assunta I., et al. (2013).  GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.. Eur J Obstet Gynecol Reprod Biol. 166(1), 43-6.
Kolibianakis, E. M., Griesinger G., & Venetis C. A. (2012).  GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data.. Hum Reprod Update. 18(2), 228-9; author reply 229-30.
Vakalopoulos, I., & Zeginiadou T. (2010).  GnRH agonist administration in the luteal phase of IVF cycles: still an experimental approach.. Reprod Biomed Online. 21(1), 148-9; author reply 150.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
Patoulias, D., Stavropoulos K., Imprialos K., Katsimardou A., Kalogirou M-S., Koutsampasopoulos K., et al. (2019).  Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs.. Diabetes Res Clin Pract. 158, 107927.
Kitsios, K., Tsapas A., & Karagianni P. (2011).  Glycemia and cardiovascular risk: challenging evidence based medicine.. Hippokratia. 15(3), 199-204.
Papanas, N., Tsapas A., Papatheodorou K., Papazoglou D., Bekiari E., Sariganni M., et al. (2010).  Glycaemic control is correlated with well-being index (WHO-5) in subjects with type 2 diabetes.. Exp Clin Endocrinol Diabetes. 118(6), 364-7.
Karagianni, P., Rallis D., Fidani L., Porpodi M., Kalinderi K., Tsakalidis C., et al. (2013).  Glutathion-S-Transferase P1 polymorphisms association with broncopulmonary dysplasia in preterm infants.. Hippokratia. 17(4), 363-7.
Goulas, A., Kosmidou M., Hatzitolios A. I., Molyva D., Fidani L., Giannopoulos S., et al. (2008).  Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients.. Basic Clin Pharmacol Toxicol. 102(6), 559-62.
Sonthalia, S., Jha A. K., Lallas A., Jain G., & Jakhar D. (2018).  Glutathione for skin lightening: a regnant myth or evidence-based verity?. Dermatol Pract Concept. 8(1), 15-21.
Tsamis, K. I., Mytilinaios D. G., Njau S. N., & Baloyannis S. J. (2013).  Glutamate receptors in human caudate nucleus in normal aging and Alzheimer's disease.. Curr Alzheimer Res. 10(5), 469-75.
Galli-Tsinopoulou, A., & Nousia-Arvanitakis S. (2000).  Glucose-6-phosphate dehydrogenase deficiency-induced hemolysis in newly diagnosed diabetic monozygotic twins.. J Pediatr Endocrinol Metab. 13(6), 669-72.
Leen, W. G., Klepper J., Verbeek M. M., Leferink M., Hofste T., van Engelen B. G., et al. (2010).  Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.. Brain. 133(Pt 3), 655-70.
Gatzioura, I., Papakonstantinou E., Dimitriadou M., Kourti M., Sidi V., Triantafyllou P., et al. (2016).  Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.. Pediatr Blood Cancer. 63(7), 1181-4.
Papakonstantinou, E., Klagas I., Karakiulakis G., Tamm M., Roth M., & Stolz D. (2018).  Glucocorticoids and β-agonists regulate the pathologic metabolism of hyaluronic acid in COPD.. Pulm Pharmacol Ther. 48, 104-110.
Anagnostis, P., Athyros V. G., Adamidou F., Panagiotou A., Kita M., Karagiannis A., et al. (2011).  Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.. Diabetes Obes Metab. 13(4), 302-12.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές